Rheumatoid arthritis patients should be offered intensive treatment when first diagnosed Evidence to support intensive treatment with disease-modifying anti-rheumatic drugs when patients are first diagnosed with rheumatoid arthritis has been presented at the Annual European Congress of Rheumatology.…
Cracking your knuckles will do you no harmScientists have used an MRI scanner to observe what happens when you crack your knuckles — a process that does not seem to cause ill health effects.…
Rheumatologists want to see system in place to track efficacy and safety of biosimilar products The British Society of Rheumatology (BSR) wants patients to register with its evidence database to track the efficacy and long-term safety of new biosimilar products.…
Infliximab biosimilars to launch in the UK as innovator product reaches patent expiryNapp Pharmaceuticals and Hospira will both launch biosimilars of Janssen Biologic’s Remicade in the UK after its patent expires on 24 February 2015.…
Forces driving the evolution of biologics into biosimilars and biobetters As demand for biologics increases, manufacturers are devising strategies to maximise their returns on investment and benefit patients.…
Still feeling the Vioxx pain Ten years after Vioxx was abruptly withdrawn from the market, its story is still affecting society’s perception of the drug regulatory system and the safety of non-steroidal anti-inflammatory drugs.…
Rheumatoid arthritis: a patient journeyThis case study aims to help you understand the diagnosis of rheumatoid arthritis, the different medicines that may be prescribed and the support you can give patients…
Rheumatoid arthritis: management Evidence in support of early and aggressive pharmacological intervention in rheumatoid arthritis continues to be gathered. DMARDs, corticosteroids and biologics are the main drugs in the armoury.…
Rheumatoid arthritis: features, causes and diagnosis Social and financial independence can be lost when a person develops severe rheumatoid arthritis. Prompt diagnosis and treatment can improve outcomes for patients and reduce costs to society.…
